Dali Pharmaceuticalco.,Ltd (603963.SS)

CNY 1.18

(0.0%)

Operating Expenses Summary of Dali Pharmaceuticalco.,Ltd

  • Dali Pharmaceuticalco.,Ltd's latest annual operating expenses in 2023 was 56.92 Million CNY , down -37.68% from previous year.
  • Dali Pharmaceuticalco.,Ltd's latest quarterly operating expenses in 2024 Q3 was 7.35 Million CNY , up 23.3% from previous quarter.
  • Dali Pharmaceuticalco.,Ltd reported a annual operating expenses of 96.95 Million CNY in annual operating expenses 2022, down -30.14% from previous year.
  • Dali Pharmaceuticalco.,Ltd reported a annual operating expenses of 138.78 Million CNY in annual operating expenses 2021, down -12.25% from previous year.
  • Dali Pharmaceuticalco.,Ltd reported a quarterly operating expenses of 7.35 Million CNY for 2024 Q3, up 23.3% from previous quarter.
  • Dali Pharmaceuticalco.,Ltd reported a quarterly operating expenses of 7.61 Million CNY for 2024 Q1, down -14.87% from previous quarter.

Annual Operating Expenses Chart of Dali Pharmaceuticalco.,Ltd (2023 - 2012)

Historical Annual Operating Expenses of Dali Pharmaceuticalco.,Ltd (2023 - 2012)

Year Operating Expenses Operating Expenses Growth
2023 56.92 Million CNY -37.68%
2022 96.95 Million CNY -30.14%
2021 138.78 Million CNY -12.25%
2020 158.14 Million CNY -24.95%
2019 210.72 Million CNY -32.48%
2018 312.08 Million CNY 129.02%
2017 136.26 Million CNY 142.99%
2016 56.07 Million CNY 9.75%
2015 51.09 Million CNY 6.2%
2014 48.11 Million CNY 7.93%
2013 44.58 Million CNY -5.8%
2012 47.32 Million CNY 0.0%

Peer Operating Expenses Comparison of Dali Pharmaceuticalco.,Ltd

Name Operating Expenses Operating Expenses Difference
China Animal Husbandry Industry Co., Ltd. 665.77 Million CNY 91.449%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.77 Billion CNY 96.784%
Yabao Pharmaceutical Group Co., Ltd 1.43 Billion CNY 96.041%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.28 Billion CNY 95.586%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 1.58 Billion CNY 96.412%
Kangmei Pharmaceutical Co., Ltd. 628.4 Million CNY 90.941%
Tasly Pharmaceutical Group Co., Ltd 4.56 Billion CNY 98.753%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 3.04 Billion CNY 98.133%
Hubei Jumpcan Pharmaceutical Co., Ltd. 4.61 Billion CNY 98.766%
Shandong Lukang Pharmaceutical Co.,Ltd. 1.18 Billion CNY 95.211%
North China Pharmaceutical Company Ltd. 3.05 Billion CNY 98.138%
Zhejiang Shengda Bio-Pharm Co., Ltd. 119.2 Million CNY 52.243%
Zhejiang Starry Pharmaceutical Co.,Ltd. 484.13 Million CNY 88.241%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 859.39 Million CNY 93.376%
Shandong Buchang Pharmaceuticals Co., Ltd. 8.48 Billion CNY 99.329%
Guobang Pharma Ltd. 550.06 Million CNY 89.65%
ChengDu ShengNuo Biotec Co.,Ltd. 196.27 Million CNY 70.994%
Changchun BCHT Biotechnology Co. 1.08 Billion CNY 94.764%
Shanghai Haoyuan Chemexpress Co., Ltd. 720.84 Million CNY 92.102%
Zhejiang Huahai Pharmaceutical Co., Ltd. 3.89 Billion CNY 98.539%
Harbin Pharmaceutical Group Co., Ltd. 3.39 Billion CNY 98.322%
Zhejiang Medicine Co., Ltd. 2.14 Billion CNY 97.345%
HPGC Renmintongtai Pharmaceutical Corporation 586.72 Million CNY 90.297%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 2.52 Billion CNY 97.742%
Lionco Pharmaceutical Group Co.,Ltd. 235.93 Million CNY 75.871%
Humanwell Healthcare (Group) Co.,Ltd. 7.77 Billion CNY 99.268%
Ginwa Enterprise (Group) Inc. 473.93 Million CNY 87.988%
KPC Pharmaceuticals, Inc. 2.88 Billion CNY 98.026%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 334.81 Million CNY 82.997%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 516.66 Million CNY 88.981%
Ningbo Menovo Pharmaceutical Co., Ltd. 323.95 Million CNY 82.427%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 904.15 Million CNY 93.704%
Nanjing Well Pharmaceutical Group Co.,Ltd. 195.02 Million CNY 70.809%
Henan Lingrui Pharmaceutical Co., Ltd. 1.77 Billion CNY 96.785%
Joincare Pharmaceutical Group Industry Co.,Ltd. 6.84 Billion CNY 99.168%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 4.1 Billion CNY 98.612%
Chongqing Taiji Industry(Group) Co.,Ltd 6.47 Billion CNY 99.12%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 9.06 Billion CNY 99.372%
China National Medicines Corporation Ltd. 1.04 Billion CNY 94.562%
Shenzhen Chipscreen Biosciences Co., Ltd. 617.41 Million CNY 90.779%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.73 Billion CNY 96.724%
Zhongzhu Healthcare Holding Co.,Ltd 281 Million CNY 79.74%
Beijing Tongrentang Co., Ltd 5.21 Billion CNY 98.909%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 679.56 Million CNY 91.623%
Jianmin Pharmaceutical Group Co.,Ltd. 1.56 Billion CNY 96.371%
Tibet Weixinkang Medicine Co., Ltd. 497.13 Million CNY 88.549%
CanSino Biologics Inc. 1.49 Billion CNY 96.186%
Zhejiang Hisun Pharmaceutical Co., Ltd. 3.96 Billion CNY 98.564%
Shanghai Jiaoda Onlly Co.,Ltd 92.17 Million CNY 38.241%
Jiang Zhong Pharmaceutical Co.,Ltd 1.97 Billion CNY 97.115%
Mayinglong Pharmaceutical Group Co., LTD. 778.04 Million CNY 92.683%
Cisen Pharmaceutical Co., Ltd. 2.01 Billion CNY 97.175%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 249.26 Million CNY 77.161%
Hunan Warrant Pharmaceutical Co.,Ltd 691.12 Million CNY 91.763%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 17.16 Billion CNY 99.668%
Hunan Fangsheng Pharmaceutical Co., Ltd. 912.55 Million CNY 93.762%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 245.55 Million CNY 76.816%
Henan Taloph Pharmaceutical Stock Co.,Ltd 520.55 Million CNY 89.064%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 2.19 Billion CNY 97.409%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 334.18 Million CNY 82.965%
Shanghai Shyndec Pharmaceutical Co., Ltd. 3.54 Billion CNY 98.394%
Shanghai Yizhong Pharmaceutical Co., Ltd. 175.02 Million CNY 67.474%
Tibet Rhodiola Pharmaceutical Holding Co. 2.07 Billion CNY 97.258%
Sichuan Huiyu Pharmaceutical Co., Ltd. 672.26 Million CNY 91.532%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 869.22 Million CNY 93.451%